Antibe Therapeutics Inc. (ATBPF) News Nov 11, 2014
Post# of 250675

MarketWatch News on ATBPF
No News currently available for ATBPF
Advertisement
Other News on ATBPF
No News currently available for ATBPF
Press Releases on ATBPF
Antibe Therapeutics Completes Single Ascending Dose Portion of ATB-346 Phase I Program 6:30 a.m. Oct. 6, 2014 - BusinessWire - BZX
Antibe Therapeutics Reports on Results of AGM Voting 6:30 a.m. Oct. 3, 2014 - BusinessWire - BZX
Merriman Capital Announces Sponsorship of Antibe Therapeutics Inc. on OTCQX 8:02 a.m. Sept. 15, 2014 - Thomson Reuters ONE
Antibe Therapeutics Commences Trading on the US OTCQX Marketplace 6:31 a.m. Sept. 15, 2014 - BusinessWire - BZX
OTC Markets Group Welcomes Antibe Therapeutics to OTCQX® 6:00 a.m. Sept. 15, 2014 - PR Newswire - PRF
Antibe Therapeutics’ Founder Leads Study Identifying a Novel Mechanism for Treating Inflammatory Bowel Disease 6:31 a.m. Sept. 5, 2014 - BusinessWire - BZX
Antibe Therapeutics Reports Q1 2015 Interim Financial and Operating Results 7:01 a.m. Aug. 28, 2014 - BusinessWire - BZX

